DAMORA THERAPEUTICS INC (DMRA) Stock Balance Sheet
NASDAQ:DMRA • US36322Q2066
Current stock price
25.09 USD
+0.01 (+0.04%)
At close:
25.56 USD
+0.47 (+1.87%)
After Hours:
| 2025 (2025-12-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 257.62M | 14.18M | 21.46M | 32.80M | 62.60M | |||
| Marketable Securities | N/A | 0.00 | 11.69M | 27.40M | 37.60M | |||
| Receivables | 1.25M | 881.00K | 2.76M | 2.80M | 7.80M | |||
| Other Current Assets | 1.55M | 1.78M | 859.00K | 900.00K | 2.00M | |||
| Total Current Assets | 260.42M | 16.84M | 36.77M | 63.90M | 110.10M | |||
| Non-Current Assets | ||||||||
| PPE Net | 104.00K | 130.00K | 325.00K | 1.20M | 1.00M | |||
| Investments And Advances | N/A | N/A | 0.00 | 5.80M | 9.00M | |||
| Other Non-Current Assets | 0.00 | 163.00K | 1.13M | 2.30M | 2.00M | |||
| Total Non-Current Assets | 104.00K | 293.00K | 1.45M | 9.30M | 12.10M | |||
| TOTAL ASSETS | 260.53M | 17.13M | 38.23M | 73.20M | 122.20M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Accrued Expenses | 1.04M | 216.00K | 2.90M | 1.10M | 1.00M | |||
| Accounts Payable | 17.66M | 377.00K | 1.70M | 3.40M | 1.50M | |||
| Other Current Liabilities | 1.36M | 604.00K | 1.22M | 6.70M | 2.00M | |||
| Total Current Liabilities | 20.07M | 1.20M | 5.83M | 11.10M | 4.50M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other Non-Current Liabilities | 81.00K | 104.00K | 66.00K | 300.00K | 400.00K | |||
| Total Non-Current Liabilities | 81.00K | 104.00K | 66.00K | 300.00K | 500.00K | |||
| TOTAL LIABILITIES | 20.15M | 1.30M | 5.90M | 11.40M | 5.00M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -487.36M | -277.52M | -256.08M | -217.70M | -156.10M | |||
| Additional Paid In Capital | 310.69M | 291.90M | 288.04M | 279.70M | 273.70M | |||
| Common Shares | 416.25M | 1.36M | 300.00 | 0.00 | 0.00 | |||
| Other Shareholders' Equity | 802.00K | 97.00K | 379.70K | -200.00K | -300.00K | |||
| Shares Outstanding | 1.60M | 1.32M | 1.08M | 25.70M | 25.30M | |||
| Tangible Book Value per Share | -110.11 | 10.99 | 29.81 | 2.40 | 4.63 | |||
| Total Shareholders' Equity | 240.38M | 15.83M | 32.33M | 61.80M | 117.20M | |||
| TOTAL LIABILITIES AND EQUITY | 260.53M | 17.13M | 38.23M | 73.20M | 122.20M | |||
| Statistics | ||||||||
| Current Ratio | 12.98 | 14.07 | 6.31 | 5.76 | 24.47 | |||
| Return On Assets (ROA) | -80.54% | -125.14% | -100.32% | -84.18% | -42.35% | |||
| Return On Equity (ROE) | -87.29% | -135.42% | -118.61% | -99.71% | -44.16% | |||
All data in USD , ROIC based on taxRate of 0.21